Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials
2018 · Leukemia · 70 citations
https://doi.org/10.1038/s41375-018-0163-4
G
Gulnaz Iqbal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
504
Citations
11
h-index
15
i10-index
Gulnaz Iqbal is an academic researcher from University of Azad Jammu and Kashmir. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Migration, Health and Trauma & Neutropenia and Cancer Infections. The author has an h-index of 11, co-authored 35 publications.
ORCID: 0000-0002-1391-6021Papers by this author
worksImproving ethnicity data collection for health statistics in the UK
2009 · SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University) · 19 citations
Use of patient diaries in conjunction with standard reporting methods: duplication of data or a valuable resource?
2015 · Trials · 3 citations
https://doi.org/10.1186/1745-6215-16-s2-p183
Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial
2022 · Blood Cancer Journal · 3 citations
https://doi.org/10.1038/s41408-022-00758-7
Exploring the effect of differing centre hydration and anti-emetic policies on acute gastrointestinal and renal toxicities in the De-ESCALaTE trial
2025 · BJC Reports · 0 citations
https://doi.org/10.1038/s44276-025-00132-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat